Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a site version update. This is a metadata update and does not alter the study details or how users interact with the record.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a small update to the study record.SummaryDifference0.0%

- Check37 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer release of the study page. This internal update does not alter the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check52 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A formatting tweak changes 'Intervention / Treatment' to 'Intervention/Treatment' and the revision label updated to Revision: v3.6.0.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page’s footer revision label changed from v3.5.4 to v3.5.5, indicating an updated site release. This is an internal metadata update and does not alter the study details or other user-facing content on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision has been updated to v3.5.4. This indicates an updated site version rather than any modification to the study data or content.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.